Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation

Published:2009-06 Issue:6 Volume:15 Page:694-703
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Nakamae Hirohisa,Kirby Katharine A.,Sandmaier Brenda M.,Norasetthada Lalita,Maloney David G.,Maris Michael B.,Davis Chris,Corey Lawrence,Storb Rainer,Boeckh Michael

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference25 articles.

1. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablativetherapy;Giralt;Blood,1997

2. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases;Slavin;Blood,1998

3. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects;McSweeney;Blood,2001

4. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect;Feinstein;Ann N Y Acad Sci,2001

5. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies;Maris;Blood,2003

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan;Journal of Microbiology, Immunology and Infection;2024-06

2. Comparative analysis of the impact of cytomegalovirus viremia between fully matched and haploidentical hematopoietic stem cell transplants in acute leukemia patients;The Egyptian Journal of Haematology;2024-04

3. The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients;Blood Advances;2023-03-06

4. Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2022-07

5. PCR analysis of CMV in hematology patients;Demiroglu Science University Florence Nightingale Journal of Medicine;2021-12-01